Callan JMB Inc. - SIC # 2642 -

Ticker Exchange SIC # Website Latest Ticker
CJMB Nasdaq 2642 callanjmb.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Callan JMB Inc.

Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure - Apr 20th, 2026 6:00 am
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC - Apr 17th, 2026 3:00 pm
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer - Apr 7th, 2026 6:45 am
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update - Mar 31st, 2026 2:05 pm
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement - Mar 27th, 2026 6:45 am
DifGen Pharmaceuticals and Aveva Drug Delivery Systems Lead U.S. Technology Transfer and Platform Development Collaboration for Multi-Indication Immune Restoration Therapy with Active IND Programs and Phase 2b/3 Authorization in PASC - Mar 25th, 2026 6:37 am
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID - Mar 11th, 2026 6:45 am
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026 - Mar 10th, 2026 7:00 am
iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10–11, 2026 - Mar 4th, 2026 7:00 am
Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026 - Mar 2nd, 2026 6:45 am
Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026 - Feb 27th, 2026 6:45 am
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event - Jan 23rd, 2026 12:50 pm
Callan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026 - Jan 20th, 2026 7:00 am
Top Midday Gainers - Jan 15th, 2026 12:05 pm
BC-Most Active Stocks - Jan 15th, 2026 8:30 am
Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue - Jan 15th, 2026 6:45 am
Callan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility - Jan 12th, 2026 6:00 am
Founder of Callan JMB Picks Up 1.3% More Stock - Dec 15th, 2025 3:02 am
Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update - Nov 14th, 2025 2:05 pm
Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility - Nov 13th, 2025 7:00 am